ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Otolaryngology

Top Otolaryngology Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANDALL REAL M.D.

Otolaryngology

2,096

$75.7K

660
468 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 19%

$36
Average prescription price

Avg: $44

JOHN JEBELES M.D.

Otolaryngology

1,993

$57.1K

541
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 19%

$29
Average prescription price

Avg: $44

JOHN POYNOR M.D.

Otolaryngology

1,751

$56.3K

589
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 19%

$32
Average prescription price

Avg: $44

DANIEL ORTIZ D.O.

Otolaryngology

1,720

$133K

321
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 19%

$77
Average prescription price

Avg: $44

MARK GACEK M.D.

Otolaryngology

1,707

$83.7K

509
411 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 19%

$49
Average prescription price

Avg: $44

DARBY MARSHALL MD

Otolaryngology

1,595

$96.2K

362
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 19%

$60
Average prescription price

Avg: $44

ROSS GARDNER MD

Otolaryngology

1,358

$33.1K

378
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 19%

$24
Average prescription price

Avg: $44

JAMES HARRISON M.D.

Otolaryngology

1,335

$60.1K

372
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 19%

$45
Average prescription price

Avg: $44

ALICE MORGAN M.D., PH.D.

Otolaryngology

1,261

$47.8K

235
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 19%

$38
Average prescription price

Avg: $44

THOMAS DOWLING M.D.

Otolaryngology

1,229

$32.9K

311
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 19%

$27
Average prescription price

Avg: $44

WILLIAM MCFEELY M.D.

Otolaryngology

1,226

$47.2K

245
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 10%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$39
Average prescription price

Avg: $44

WILLIAM BLYTHE M.D.

Otolaryngology

1,166

$46.7K

315
204 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 19%

$40
Average prescription price

Avg: $44

WARREN STILES M.D.

Otolaryngology

1,142

$48.4K

300
173 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 19%

$42
Average prescription price

Avg: $44

ROBERT OSTENDORF M.D.

Otolaryngology

1,074

$38.8K

243
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 19%

$36
Average prescription price

Avg: $44

DOUGLAS LOWERY M.D.

Otolaryngology

1,050

$38.2K

396
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 19%

$36
Average prescription price

Avg: $44

JAMES PITCOCK M.D.

Otolaryngology

1,039

$28.5K

374
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 19%

$27
Average prescription price

Avg: $44

RICHARD CALDWELL M.D.

Otolaryngology

1,028

$40.5K

321
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 19%

$39
Average prescription price

Avg: $44

SCOT CALLAHAN MD

Otolaryngology

1,003

$48.8K

196
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$49
Average prescription price

Avg: $44

JAMES SPIRES M.D.

Otolaryngology

984

$36.8K

310
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$37
Average prescription price

Avg: $44

MORTON GOLDFARB M.D.

Otolaryngology

962

$41.7K

244
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$43
Average prescription price

Avg: $44

FRANCIS LONG MD

Otolaryngology

936

$43K

302
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 19%

$46
Average prescription price

Avg: $44

EMMETT ELLEDGE MD

Otolaryngology

934

$46.2K

323
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 19%

$49
Average prescription price

Avg: $44

SCOTT CHARLTON M.D.

Otolaryngology

908

$45.2K

270
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 19%

$50
Average prescription price

Avg: $44

WESLEY WHATLEY MD

Otolaryngology

903

$30.9K

264
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 19%

$34
Average prescription price

Avg: $44

RUTILIO GARCIA M.D.

Otolaryngology

886

$19.3K

356
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 19%

$22
Average prescription price

Avg: $44

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank